Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies

Clinical trial NCT01919619 · COMPLETED

Trial details

NCT number: NCT01919619
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Non-Hodgkin Lymphoma Hematopoietic and Lymphoid Cell Neoplasm Leukemia Lymphoma Plasma Cell Myeloma T-Cell Non-Hodgkin Lymphoma

Start date: 2013-11-04
Primary completion: 2024-05-03
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.